Antagonistic effects of ultra-low-molecular-weight heparin against cerebral ischemia/reperfusion injury in rats

Pharmacological Research

Volumn 56, Issue 4, 2007, Pages 350-355

  Zhang, Zhi guo ^a   Zhang, Qing zhu ^a   Cheng, Yan na ^a   Ji, Sheng li ^a   Du, Guan hua ^b  

^a SHANDONG UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Focal cerebral ischemia; Middle cerebral artery occlusion (MCAO); Neuroprotection; Ultra low molecular weight heparin (ULMWH)

Indexed keywords

HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; ULTRA LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN INFARCTION; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG ANTAGONISM; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SPECTROPHOTOMETRY; WISTAR RAT;

ANIMALS; BODY WEIGHT; BRAIN; BRAIN ISCHEMIA; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; INJECTIONS, INTRAVENOUS; MALE; MALONDIALDEHYDE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY; SUPEROXIDE DISMUTASE;

EID: 34848899187     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.08.004     Document Type: Article

References (29)

1. Wong K.S., Chen C., Ng P.W., Tsoi T.H., Li H.L., Fong W.C., et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol 6 (2007) 407-413
2. Seshadri S., Beiser A., Kelly-Hayes M., Kase C.S., Au R., Kannel W.B., et al. The lifetime risk of stroke: estimates from the Framingham study. Stroke 37 (2006) 345-350
3. Kay R., Woo J., Kreel L., Wong H.Y., Teoh R., and Nicholls M.G. Stroke subtypes among Chinese living in Hong Kong: the Shatin Stroke Registry. Neurology 42 (1992) 985-987
4. Li P.A., He Q.P., Siddiqui M.M., and Shuaib A. Posttreatment with low molecular weight heparin reduces brain edema and infarct volume in rats subjected to thrombotic middle cerebral artery occlusion. Brain Res 801 (1998) 220-223
5. Quartermain D., Li Y.S., and Jonas S. The low molecular weight heparin enoxaparin reduces infarct size in a rat model of temporary focal ischemia. Cerebrovasc Dis 16 (2003) 346-355
6. Ma Q., Dudas B., Hejna M., Cornelli U., Lee J.M., Lorens S., et al. The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3. Thromb Res 105 (2002) 447-453
7. Zhang Y.Y., Wang X.Y., Wang X.R., Xu Z.H., Liu Z., Ni Q., et al. Protective effect of flavonoids from Scutellaria baicalensis Georgi on cerebral ischemia injury. J Ethnopharmacol 108 (2006) 355-360
8. Culmsee C., and Krieglstein J. Emerging pharmacotherapeutic strategies for the treatment of ischemic stroke. Drug Discov Today Ther Strat 3 (2006) 621-628
9. Longa E.Z., Weinstain P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
10. Grynkiewicz G., Poenie M., and Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260 (1985) 3440-3450
11. Love S. Oxidative stress in brain ischemia. Brain Pathol 9 (1999) 119-131
12. White B.C., Sullivan J.M., DeGracia D.J., O'Neil B.J., Neumar R.W., Grossman L.I., et al. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179 (2000) 1-33
13. Margaill I., Plotkine M., and Lerouet D. Antioxidant strategies in the treatment of stroke. Free Radic Biol Med 39 (2005) 429-443
14. Fuh K.C., Meneshian A., Patel C.B., Takiar V., and Bulkley G.B. Signal transduction by reactive oxygen species: alternative paradigms for signaling specificity. Surgery 131 (2002) 601-661
15. Durukan A., and Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87 (2007) 179-197
16. Samama M.M., Desnoyers P.C., Conard J., and Bousser M.G. Acute ischemic stroke and heparin treatments. Thromb Haemost 78 (1997) 173-179
17. Kay R., Wong K.S., Yu Y.L., Chan Y.W., Tsoi T.H., Ahuja A.T., et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 333 (1995) 1588-1593
18. The FISS bis Investigators Group. Fraxiparine in ischemic Stroke Study (FISS bis). Cerebrovasc Dis 8 Suppl. 4 (1998) 19-26
19. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 279 (1998) 1265-1272
20. Berge E., and Sandset P.M. Heparin in Acute Embolic Stroke Trial (HAEST). Cerebrovasc Dis S1 (1999) 127
21. Diener H.C., Ringelstein E.B., von Kummer R., Langohr H.D., Bewermever H., Landgraf H., et al. Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the TOPAS trial. Stroke 32 (2001) 22-29
22. Bath P.M., Lindenstrom E., and Boysen G. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet 358 (2001) 702-710
23. Rogers D.C., Campbell C.A., Stretton J.L., and Mackay K.B. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 28 (1997) 2060-2066
24. Candelario-Jalil E., Alvarez D., Merino N., and Leon O.S. Delayed treatment with nimesulide reduces oxidative stress following global ischemic brain injury in gerbils. Neurosci Res 47 (2003) 245-253
25. Al-Majed A.A. Aminoguanidine prevents oxidative stress insult following transient forebrain ischemia in the rat hippocampus. Saudi Pharm J 12 (2004) 150-156
26. Borsello T., Clarke P.G., Hirt L., Vercelli A., Repici M., Schorderet D.F., et al. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med 9 (2003) 1180-1186
27. Giuliani D., Mioni C., Altavilla D., Leone S., Bazzani C., Minutoli L., et al. Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 147 (2006) 1126-1135
28. 7]α-melanocytestimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils. Eur J Pharmacol 538 (2006) 48-56
29. Williams A.J., Berti R., Dave J.R., Elliot P.J., Adams J., and Tortella F.C. Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519. Stroke 35 (2004) 1186-1191